DACEPTON sol inj 30 mg/3ml 5 cartouche 3 ml

7680670680011 CH-67068 N04BC07 01.08.0.

Reimbursement limitations:

DACEPTON.30

Après accord sur la prise en charge des frais par la caisse maladie suite à …

DACEPTON sol inj 30 mg/3ml 5 cartouche 3 ml
DACEPTON sol inj 30 mg/3ml 5 cartouche 3 ml
DACEPTON sol inj 30 mg/3ml 5 cartouche 3 ml
1 / 3
google

Details

Product number
6706801
CPT
-
Packaging group
5 x 3 ml
Unit
Patrone(n)
Composition
apomorphini hydrochloridum hemihydricum 10 mg, antiox.: E 223 1 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Dacepton 10 mg/ml, Injektionslösung in einer Patrone
Injektionslösung in einer Patrone
5 x 3 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/01/2022
Patient information leaflet
Français
18/01/2022
Patient information leaflet
Italien
18/01/2022
Professional SmPC
Allemand
18/01/2022
Professional SmPC
Français
18/01/2022

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
1.0 MG Substance ANTOX
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 168.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2023

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
67068
Drug name
Dacepton 10 mg/ml, Injektionslösung in einer Patrone
Galenic form
LSPA
ATC Code
N04BC07
Authorization status
Z
Dispensation category
B
First authorization
06/12/2018
Authorization expiration date
31/12/9999
IT number
01.08.0.
Domain
Human medicine
Field of application
Morbus Parkinson

Packaging details

Description (FR)
DACEPTON sol inj 30 mg/3ml 5 cartouche 3 ml
Description (DE)
DACEPTON Inj Lös 30 mg/3ml 5 Patrone 3 ml
Market launch
06/12/2018
Narcotic (BTM)
No

Other packaging sizes